Arcutis Appoints Interim Chief Financial Officer (CFO)
18. August 2023 16:30 ET
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful...
Sienna Biopharmaceuticals Appoints John W. Smither as Chief Financial Officer
21. März 2018 17:30 ET
|
Sienna Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced the appointment of John W. Smither as the Company’s Chief Financial...